Avid Bioservices Inc (CDMO)

[cjgaddy]

UPCOMING EVENTS – getting seriously difficult to keep up with them all. Best I can do at the moment…

Source for many: http://ir.peregrineinc.com/events.cfm

Dec10: FY'14/Q2 (q/e 10-31-13) Financials & Conf. Call at 4:30pmET - Transcript: http://tinyurl.com/mw776mk

Jan28-30/Avid: “18th CASSS WCBP Symposium”, WashDC https://m360.casss.org/event.aspx?eventID=72301
…“18th Symposium on the Interface of Regulatory & Analytical Sciences for Biotechnology Health Products”
…CASSS = “The California Separation Science Society” (4000 members); WCBP = "Well Characterized Biotechnology Pharmaceutical"

Jan29: Arena’s 6th Annual Outsourcing in Clinical Trials Conf./SanFran http://tinyurl.com/kcda5pv
…1:15pmPT: Steve DeMattos (PPHM’s Sr.Dir. Clinical Research), “Case Study: Investigating Results from Piloting a Team-Based Approach to Vendor Mgt. for a Global Multi-Site Trial to Ensure Efficient Trial Control”

Jan30: GTC’s “Novel Immunotherapeutics Summit 2014”, SanDiego http://tinyurl.com/kmlrkzk
…5:25pm: PPHM’s Bruce Freimark (Dir./ProdDev), “PS-Targeting Antibodies Enhances Activity of Immune Checkpoint Inhibitors and Re-activates Immune System in Tumors”

Feb25-26: RBC Capital Markets HC Conf., NYC http://www.rbccm.com/about/cid-202541.html

Mar3-5: Cowen & Co. 34th Annual HC Conf., Boston http://www.cowen.com/conferences/upcoming-conferences/

Mar9-12: “Roth 26th Annual Conf.”, DanaPt/CA http://www.roth.com/main/page.aspx?PageID=7214 ;

~Mar11: FY'14/Q3 (q/e 1-31-14) Financials & Conf. Call http://ir.peregrineinc.com/events.cfm

Mar12: ITOC1/ECCO’s 1st Immunotherapy of Cancer Conf., Munich http://www.ecco-org.eu/Events/ITOC1.aspx & http://tinyurl.com/lr6r23e
…ECCO = European CanCer Organization, IOTC1=1st Immunotherapy of Cancer Conference
…3-12-14 4:30pm: Joe Shan (VP/Clin+Reg), Plenary/Cancer Immunology: “Bavituximab: A Novel PS-Targeting Immunotherapy for the Treatment of Cancer”

Mar9-14: Keystone Conf: Immune Evolution in Cancer, Whistler, BC http://www.keystonesymposia.org/14X2
...Sponsored by: Bristol-Myers Squibb, Genentech, OncoMed, Roche, Vertex. “We gratefully acknowledge additional support for this conference from: Peregrine Pharmaceuticals”
• Xianming Huang (PhD, UTSW/Dallas): “PS-Targeting Antibodies Induce M1 Macrophage Polarization, Promote Myeloid Derived Suppressor Cell Differentiation & Boost Tumor-Specific Immunity” (14:40-16:30 Workshop 3: Immune Suppressive Myeloid Cells)
• Bruce Freimark (PhD, Dir./Preclin.Dev): “PS-Targeting Antibodies Enhance the Activity of Immune Checkpoint Inhibitors in Tumors”

Mar9-14: Keystone Conf: HIV Pathogenesis - Virus vs. Host, Banff, Alberta http://www.keystonesymposia.org/index.cfm?e=web.meeting.program&meetingid=1288
• Cyril Empig (PhD, Assoc.Director/Pre-Clin Res./Infectious Disease): “PS-targeting ANTIBODY Triggers B-Chemokine Release from Monocytes by Cell-Cell Crosslinking and is a Potent Inhibitor of HIV-1 In Vitro”

Mar13: Society of Surgical Oncology Cancer Symposium (2014 SSO), Phoenix http://www.sso2014.org ;
• Adam Yopp (MD, Assist.Prof.Surgery, UTSW/Dallas): “Combination of Bavituximab and Sorafenib Inhibits HCC Growth: Results of Preclinical Data and a Phase I Study”

Mar24-27/Avid/Booth#304: IBC’s “Biopharm. Dev. & Prod. Week”, SanDiego http://www.ibclifesciences.com/BDPWeek

Mar25 12-4pm: "NYAS Symposium on Lung Cancer”, NYC http://tinyurl.com/kr8k72w
…Dr. Rolf Brekken (UTSW, SAB/PPHM) one of 3 speakers, symposium titled, “Lung Cancer: Advances in Current Treatment Modalities & Patient Classification” – organizers include BI-Pharm, Forest-Res-Inst., George Zavoico

Q1-2014/ORAL-PRES/"Upcoming Sci.Conf": Interim Data from Bavi+ Sorafenib(Nexavar) LIVER Ph1/2 IST http://tinyurl.com/mw776mk

Apr5-9: AACR 105th Annual Meeting (SanDiego) http://www.aacr.org/home/scientists/meetings--workshops/aacr-annual-meeting-2014.aspx

May6: IBC’s 24th Biological Assays: Accelerating Your Dev. & Validation Practices, Berkeley, CA
…4:45pm: Gary Larson, Sen.Sci./PPHM, “CASE STUDY - “Dev. of a Bifunctional Mab Lot Release Bioassay”

May30-Jun3: ASCO 50th Annual Meeting (Chicago) http://am.asco.org